Investors in Science

MIT EF CEE accelerator is affiliated with the world-renowned Massachusetts Institute of Technology (MIT). The Start Smart CEE (formerly MIT Enterprise Forum CEE) is a global organization of dedicated professionals with local chapters, affiliated with the Massachusetts Institute of Technology (MIT) through MIT Technology Review. We are open to all participants of the entrepreneurial ecosystem.

LSI is a pre-seed and seed stage venture capital in Poland. We invest in early-stage start ups in life science domain. LSI is a Venture Capital Fund focused on polish life science startups in pre-seed and seed stages. We currently have 11 start-ups in our portfolio. We have startups in the field of medtech, digital health, biotech, environment protection.

Novalis Biotech Incubation is an early-stage venture capital fund that invests in biotechnology and life sciences related companies. Focusing on enabling technologies in healthcare, such as digital health, diagnostics, genomics and bio-informatics. We focus on early-stage start-ups, from (pre-)seed stage to series A, and support their evolution by providing funding, sharing our professional and academic connections, and help to shape the business strategy in order to create value for all stakeholders.

SmiLe Incubator helps entrepreneurs and startup companies to develop and commercialize new ideas. Surrounded by smart and passionate people, as well as the best tools and approaches at your disposal – you’ll take leaps toward creating a business and connecting with the right people and resources. We offer business coaching, access to investor & industry networks, access to labs & instrument as well as a community with colleagues, friends and peers.

Heliad's mission is to empower both entrepreneurs and investors. They find, fund, and support market-leading companies across various verticals and regions to power their next phase of growth. As a listed company and through their strong team and strategic partners, they support companies pre, at, and post IPO and act as a gateway to public equity capital markets.

Pioneer Group is a vertically integrated platform curating innovation-focused ecosystems that increase the chance of business success. Pioneer Group connects your life sciences company to lab space, offices and business accelerator programmes to help you launch, grow and scale. We Create Places Where Life Sciences Grow, Labs, Accelerator, Investment.

re.Mind Capital is a venture capital fund founded by Christian Angermayer, together with partners Jan Hardorp and Max de Vere. Venture capital fund dedicated to mental and neurological health. They focus on new pharma, new modalities, brain computer interfaces and digital health.

Growing Capital is an early-stage investment firm established in 2015 and headquartered in Dublin, focusing on supporting Irish startups. They have backed over 25 startups, including notable successes like Glofox, Caragon, Flipdish, and ScalaPay. Growing Capital targets early-stage Irish software startups with a B2B business model, offering initial investments from €50K to €100K and prioritizing companies emerging from pre-accelerator programs. They seek founders who are problem solvers with the potential to lead and grow their businesses to at least €2 million ARR within three years.

Seroba is a leading European life sciences venture capital firm, dedicated to creating value by supporting innovative biotech and medtech companies. With a focus on breakthrough technologies, Seroba has backed significant advancements such as Shorla Oncology's FDA-approved TEPYLUTE, a ready-to-dilute formulation for treating breast and ovarian cancer. Based in Dublin, Seroba leverages deep industry expertise to help entrepreneurs build world-class businesses, fostering extraordinary scientific innovations.

"Impetus Capital is an early-stage venture capital fund specializing in backing strong founding teams focused on building rapidly growing tech companies poised for global expansion. They target companies in the early stage with post-traction, typically investing initial tickets ranging from EUR 0.3m to 0.5m. Impetus Capital is committed to long-term support, particularly for companies that have demonstrated double-digit growth potential. With a strategic focus on Central and Eastern Europe (CEE), Impetus Capital prioritizes investments in CEE-based companies, with a preference for those with a Bulgarian angle. Their investment approach aims to foster growth and innovation within the region's tech ecosystem while facilitating global scalability for their portfolio companies."

Oscar & Paul operates as a corporate venture capital firm of Beiersdorf.At O&P Beiersdorf Venture Capital, we are dedicated to shaping the future of skin care by creating innovative solutions that enhance people's well-being in their skin. Through collaboration with startups and corporations.

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success.